 |
Liposome encapsulated recombinant interleukin-2 |
|---|---|
| Trade Name | |
| Orphan Indication | Cancers of the kidney and renal pelvis |
| USA Market Approval | USA |
| USA Designation Date | 1994-06-20 00:00:00 |
| Sponsor | Oncothyreon Canada, Inc.;2011 - 94th Street NW, Canada T6N 1H1; |
